Page 10 of this presentation (financial back-test based on actual NEM prices for 3 years leading up to Feb 2017 Revenue between $13.8M and $16.8M, EBITDA between $12.2M 1nd $15.2M.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025